zumatek
Chapel Hill · Founded 2005
About zumatek
ZumaTek, Inc. develops 3D dedicated imaging technologies for the lesion detection to treat breast cancer before it has formed a tumor or spread to lymph nodes. It develops devices that are used to monitor the progress of radiation therapy or chemotherapy in breast cancer patients as it is able to non-invasively detect chemical changes in the cancer cells. The company’s devices can also be combined with on-board biopsy or treatment devices. ZumaTek was incorporated in 2005 and is based in Chapel Hill, North Carolina.
Company Facts
- Founded: 2005
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $150.0K
- Last round: Debt Financing (Nov 2010)
- Website: zumatek.com
- Phone: 919-225-3965
Canonical: https://fsome.com/organization/zumatek-8442827 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.